Mackay Shields LLC’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,820
| Closed | -$653K | – | 760 |
|
|
2021
Q1 | $653K | Sell |
1,820
-961
| -35% | -$345K | ﹤0.01% | 1130 |
|
|
2020
Q4 | $1.37M | Sell |
2,781
-564
| -17% | -$277K | 0.01% | 987 |
|
|
2020
Q3 | $1.08M | Sell |
3,345
-516
| -13% | -$167K | 0.01% | 1007 |
|
|
2020
Q2 | $1.41M | Buy |
3,861
+512
| +15% | +$186K | 0.01% | 905 |
|
|
2020
Q1 | $713K | Buy |
3,349
+492
| +17% | +$105K | 0.01% | 1052 |
|
|
2019
Q4 | $1.18M | Buy |
2,857
+164
| +6% | +$67.6K | 0.01% | 1036 |
|
|
2019
Q3 | $951K | Buy |
2,693
+564
| +26% | +$199K | 0.01% | 1126 |
|
|
2019
Q2 | $1.07M | Buy |
2,129
+1,489
| +233% | +$749K | 0.01% | 1105 |
|
|
2019
Q1 | $636K | Buy |
640
+20
| +3% | +$19.9K | ﹤0.01% | 1122 |
|
|
2018
Q4 | $538K | Buy |
+620
| New | +$538K | ﹤0.01% | 1124 |
|
|
2018
Q3 | – | Sell |
-536
| Closed | -$493K | – | 1136 |
|
|
2018
Q2 | $493K | Buy |
+536
| New | +$493K | ﹤0.01% | 1102 |
|